NASDAQ: ATOSAtossa Therapeutics Inc Stock Ownership - Who owns Atossa Therapeutics?
Insider buying vs selling
Have Atossa Therapeutics Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when ATOS insiders and whales buy or sell their stock.
ATOS Shareholders
What type of owners hold Atossa Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Steven C. Quay | 57.09% | 4,916,379 | $10.91M | Insider |
| Shuchih Chen | 56.19% | 4,838,341 | $10.74M | Insider |
| Vanguard Capital Management LLC | 4.05% | 349,096 | $774.99k | Institution |
| Ameriprise Financial Inc | 2.96% | 255,134 | $566.40k | Institution |
| Alexander D. Cross | 2.06% | 177,232 | $393.46k | Insider |
| Blackrock Inc | 1.55% | 133,169 | $295.64k | Institution |
| Renaissance Technologies LLC | 1.27% | 109,007 | $242.00k | Institution |
| Geode Capital Management LLC | 1.13% | 97,061 | $215.48k | Institution |
| Ubs Group Ag | 1.07% | 92,034 | $204.32k | Institution |
| Millennium Management LLC | 0.78% | 66,739 | $148.16k | Institution |
ATOS vs Biotech Stocks
Atossa Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.